Company profile: Bioceros
1.1 - Company Overview
Company description
- Provider of biopharmaceutical R&D contract services spanning discovery research to pre-clinical development, including assay development and quantification, molecular and cell biology, and services related to preclinical development of monoclonal antibodies and generation of protein-producing cell lines.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bioceros
Cambrex
HQ: United States
Website
- Description: Provider of end-to-end small molecule drug substance and drug product development and manufacturing, analytical services and testing, IND-enabling services, and process development. Supports research through commercial scale, covering various dosage forms, streamlining IND submissions, and ensuring regulatory compliance and product safety for small molecule therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrex company profile →
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
Prothya Biosolutions
HQ: Belgium
Website
- Description: Provider of plasma protein therapeutics and services, including immunoglobulin for primary/secondary immunodeficiency and neuromuscular disorders (MMN, CIDP); albumin for blood loss, burns, and sepsis; prothrombin complex and Cofact for coagulation disorders. Offers product/process development (viral safety, formulations, stability, characterization) and contract manufacturing of plasma intermediates, APIs, drug substances, and final products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prothya Biosolutions company profile →
Dinamiqs
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing services for AAV and lentiviruses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dinamiqs company profile →
US Pharma Lab
HQ: United States
Website
- Description: Provider of custom development, manufacturing, and supply services for premium dietary supplement ingredients, premixes, and products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US Pharma Lab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bioceros
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bioceros
2.2 - Growth funds investing in similar companies to Bioceros
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bioceros
4.2 - Public trading comparable groups for Bioceros
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →